[go: up one dir, main page]

GB202308238D0 - Novel Method - Google Patents

Novel Method

Info

Publication number
GB202308238D0
GB202308238D0 GBGB2308238.1A GB202308238A GB202308238D0 GB 202308238 D0 GB202308238 D0 GB 202308238D0 GB 202308238 A GB202308238 A GB 202308238A GB 202308238 D0 GB202308238 D0 GB 202308238D0
Authority
GB
United Kingdom
Prior art keywords
novel method
novel
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB2308238.1A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Babraham Institute
Original Assignee
Babraham Institute
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Babraham Institute filed Critical Babraham Institute
Priority to GBGB2308238.1A priority Critical patent/GB202308238D0/en
Publication of GB202308238D0 publication Critical patent/GB202308238D0/en
Priority to PCT/GB2024/051407 priority patent/WO2024246536A1/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/12—Antidiuretics, e.g. drugs for diabetes insipidus

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Diabetes (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Epidemiology (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
GBGB2308238.1A 2023-06-02 2023-06-02 Novel Method Ceased GB202308238D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB2308238.1A GB202308238D0 (en) 2023-06-02 2023-06-02 Novel Method
PCT/GB2024/051407 WO2024246536A1 (en) 2023-06-02 2024-05-31 Methods of promoting acetyl coenzyme a-flux in cells

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB2308238.1A GB202308238D0 (en) 2023-06-02 2023-06-02 Novel Method

Publications (1)

Publication Number Publication Date
GB202308238D0 true GB202308238D0 (en) 2023-07-19

Family

ID=87156837

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB2308238.1A Ceased GB202308238D0 (en) 2023-06-02 2023-06-02 Novel Method

Country Status (2)

Country Link
GB (1) GB202308238D0 (en)
WO (1) WO2024246536A1 (en)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002009726A1 (en) * 2000-07-31 2002-02-07 Trustees Of Boston University Methods of treating conditions associated with insulin resistance with aicar, (5-amino-4-imidazole carboxamide riboside) and related compounds

Also Published As

Publication number Publication date
WO2024246536A1 (en) 2024-12-05

Similar Documents

Publication Publication Date Title
GB202207026D0 (en) Method
GB202216162D0 (en) Method
GB202214328D0 (en) Method
GB202213924D0 (en) Method
GB202209640D0 (en) Method
GB2626230B (en) Method
GB202317286D0 (en) Novel method
GB202308238D0 (en) Novel Method
GB202300816D0 (en) Novel method
GB202206113D0 (en) Novel method
IL324542A (en) Method
GB202315883D0 (en) Method
GB202311225D0 (en) Method
GB202310796D0 (en) Method
GB202308358D0 (en) Method
GB202307096D0 (en) Method
GB202306914D0 (en) Method
GB202304769D0 (en) Method
GB202218052D0 (en) Method
GB202217510D0 (en) Method
GB202217313D0 (en) Method
GB202217032D0 (en) Method
GB202216610D0 (en) Method
GB202214502D0 (en) Method
GB202213553D0 (en) Method

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)